MACITENTAN + TADALAFIL
Macitentan 10 mg + tadalafil 40 mg tablet, 30
MACITENTAN + TADALAFIL (14828K)
14828K
Body System:
Manner of administration:Oral
Restriction
Indication: Pulmonary arterial hypertension (PAH)
Treatment phase: Continuing treatment of combination therapy (dual or triple therapy, excluding selexipag)
Restriction
Indication: Pulmonary arterial hypertension (PAH)
Treatment phase: Continuing treatment of combination therapy (triple therapy with selexipag)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $2,600.96 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Opsynvi | |||||